IL3RA and acute myeloid leukemia: According to these two studies it was suggested that in the majority of AMLs overexpressing CD123 the enhanced and deregulated signaling originated by IL-3R and FLT3 contribute to provide a survival and growth advantage to leukemic AML blasts [42].